Published Date:2025-05-21 Original Link:https://www.onenessbio.com/en/news_detail359_1.htm No 1 Date of announcement 2025/05/21 Time of announcement 20:42:12 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds for Australia. To which item it meets Subparagraph 10 Date of events  2025/05/21 Statement 1.    Date of occurrence of the event: 2025/05/21 2.    New drug name...Read More

Published Date:2025-05-16 Original Link:https://www.onenessbio.com/en/news_detail358_1.htm No 1 Date of announcement 2025/05/16 Time of announcement   16:39:51 Subject Oneness Biotech Co., Ltd. receives an United Arab Emirates patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2025/05/16 Statement Date of occurrence of the...Read More

Published Date:2025-05-12 Original Link:https://www.onenessbio.com/en/news_detail357_1.htm No 1 Date of announcement 2025/05/12 Time of announcement 16:20:01 Subject The Company’s 2025Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2025/05/12 Statement Date of the board of directors submitted or approved: 2025/05/12 Date of the audit...Read More

Published Date:2025-05-09 Original Link:https://www.onenessbio.com/en/news_detail356_2.htm No 1 Date of announcement 2025/05/09 Time of announcement 16:15:39 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by India CDSCO.  To which item it meets Subparagraph 10 Date of events  2025/05/09 Statement 1.    Date of occurrence of the event:2025/05/09 2.    New drug...Read More

Published Date:2025-04-30 Original Link:https://www.onenessbio.com/en/news_detail355_2.htm Contact Us繁簡ENRead More

Date 2025/04/28 Location San Francisco, CA Presentation Download Download Chinese Version   Download English Version   Note N/ARead More

Published Date:2025-04-23 Original Link:https://www.onenessbio.com/en/news_detail354_2.htm No 1 Date of announcement 2025/04/23 Time of announcement 17:46:40 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by Egypt EDA.  To which item it meets Subparagraph 10 Date of events  2025/04/23 Statement 1.    Date of occurrence of the event:2025/04/23 2.    New drug...Read More

  No 1 Date of announcement 2025/04/21 Time of announcement 16:50:20 Subject Oneness announces information about the first investor conference in 2025. To which item it meets paragraph 12 Date of events 2025/04/28 Statement Date of institutional investor conference: 2025/04/28 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor conference: Online Investor Conference...Read More

Published Date:2025-04-16 Original Link:https://www.onenessbio.com/en/news_detail353_2.htm No 1 Date of announcement 2025/04/16 Time of announcement 22:02:17 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Australia TGA.  To which item it meets Subparagraph 10 Date of events  2025/04/16 Statement 1.    Date of occurrence of the event:2025/04/16 2.    New drug...Read More

Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail352_2.htm No 3 Date of announcement 2025/04/10 Time of announcement 16:57:27 Subject Oneness has submitted 510(k) application of Bonvadis for full thickness wound indications to the U.S. FDA To which item it meets Subparagraph 10 Date of events  2025/04/10 Statement 1.    Date of occurrence of the event:2025/04/10 2.    New drug name or...Read More